TGRX-678 Phase I Oral Pharmacokinetic Study

NCT06697899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: TGRX-678

Sponsor

Shenzhen TargetRx Co., Ltd.

Collaborators

[object Object]